The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).
about
Clinical significance in the change of decline in ALSFRS-RSevere loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment studyRespiratory muscle training in children and adults with neuromuscular diseaseMechanical ventilation for amyotrophic lateral sclerosis/motor neuron diseaseCreatine for amyotrophic lateral sclerosis/motor neuron diseaseRepetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron diseaseTherapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron diseaseRepetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron diseaseCreatine for amyotrophic lateral sclerosis/motor neuron diseaseRepetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron diseaseMechanical ventilation for amyotrophic lateral sclerosis/motor neuron diseaseTherapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron diseaseMinocycline for amyotrophic lateral sclerosis or motor neuron diseaseElectrical impedance myography as a biomarker to assess ALS progression.Social uses of personal health information within PatientsLikeMe, an online patient community: what can happen when patients have access to one another's dataSubcutaneous IGF-1 is not beneficial in 2-year ALS trialLessons of ALS imaging: Pitfalls and future directions - A critical reviewPatient-Perceived Outcomes and Quality of Life in ALSThe clinical relevance of outcomes used in late-onset Pompe disease: can we do better?A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophyReference Range of Respiratory Muscle Strength and Its Clinical Application in Amyotrophic Lateral Sclerosis: A Single-Center StudyHead injury does not alter disease progression or neuropathologic outcomes in ALSSearching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programmeMilitary service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiologyAn Objective Functional Characterisation of Head Movement Impairment in Individuals with Neck Muscle Weakness Due to Amyotrophic Lateral SclerosisCystatin C: a candidate biomarker for amyotrophic lateral sclerosisSafety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trialInterleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis--A Pilot StudyVGF Protein and Its C-Terminal Derived Peptides in Amyotrophic Lateral Sclerosis: Human and Animal Model StudiesBeing PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?Diffusion tensor tractography analysis of the corpus callosum fibers in amyotrophic lateral sclerosisSubjects no more: what happens when trial participants realize they hold the power?Impaired structural motor connectome in amyotrophic lateral sclerosisAmyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cellsReduction of circulating endothelial cells in peripheral blood of ALS patientsWhat causes amyotrophic lateral sclerosis?Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.Characteristics of pain in amyotrophic lateral sclerosis.The checklist individual strength (CIS20-R) in patients with amyotrophic lateral sclerosis - a longitudinal study.Speech Movement Measures as Markers of Bulbar Disease in Amyotrophic Lateral Sclerosis.
P2860
Q22305679-AC88632C-F2FC-49AF-B5C4-171333CABB1AQ22305776-317A36D3-E025-4713-8227-D010A7585D20Q24188193-15A1842E-BC07-49E4-9D55-7B7C6D8A68F6Q24199018-E8D0D35D-38BF-4BAE-8477-2FC13CF10F36Q24202577-FB4E6859-8FF3-4E0C-8C97-A43108B396E9Q24202639-070FCBBB-5167-4766-97E5-16528D59FBCAQ24202648-6CC84819-206B-45BE-9E6B-31D7CC5F4A0BQ24234300-DD7BDFE6-8887-47C7-ADA0-5758CC1CC675Q24234800-D7C60599-95A8-4B72-8D8E-176B25A10CF2Q24235041-FBA313F2-6A18-459E-9A07-72E76F900084Q24240593-9B53464D-49FC-4520-AC25-13DB0EE7E66EQ24242992-90030310-C2C5-47B6-8FF7-5CE96AA39C0EQ24243793-B4EFEEB0-351D-449B-8D89-7DAD72202538Q24615680-C5576D55-0208-4FE5-AD62-EF5935626B01Q24644719-E1224016-25FE-4FAC-AD16-DB699724DE7CQ24651555-23E71E00-B6DF-4252-B7D8-C874C64B726CQ26860864-62EDD3AE-35C3-4E78-BC22-A1E357F38D6AQ26998579-FE67C13D-1FA7-46D7-8607-FA8882EC1070Q27021472-A7FEBFA4-5272-4BD5-BCB5-2BD40BBBAC5AQ28243807-810CD694-159D-48E4-9B70-973FEB059024Q28384961-90E601D0-BB3F-48F0-A5DD-699CEAEC2E2CQ28393569-9DCB962D-D235-4A97-B2D9-D48844E5219BQ28393837-5E8FE9EB-E471-4C48-BC2B-D246ED27E3ABQ28394945-AF06F3BD-B7C7-4AC4-A94C-EACAD1BC8CE1Q28469384-868B9AF3-0A37-4263-951E-DD435F403784Q28476466-3E7B2AFB-C9E7-4A9B-9E36-A7E0E0F72710Q28538939-8D99AE69-D8D3-42D9-BDE6-D7BF9A0F2D58Q28550089-019FEB60-CB3D-4347-8BC7-13EF5BAAEFE4Q28554689-8C159BEC-0B7A-48F5-9424-C726B360CAC6Q28649394-BE72A31D-987C-4D49-A20B-B3ADEE94946AQ28655620-306EAFFC-B051-4261-824E-229CC3941547Q28659882-71B798D0-0E10-4C78-B06F-633D10CEEA9CQ28740801-1D55FEA0-DE68-48E4-8163-49AE422E54AAQ28744223-F216BFE7-48F5-4B70-8258-BDAD555171C6Q28752226-9CDCBBD6-A39E-41A6-AECA-F4CD991E7B9EQ30234813-F879FBF5-7FE2-447C-A590-1DA07B5AC2BBQ30239103-88FE1A00-7B34-4890-9EBA-D8FE1954023FQ30316800-2996981E-A668-4106-859C-69CCD8CD9469Q30316804-0AB03635-997F-4ED5-B069-361EDB95546FQ30359919-73FCC3B7-83A1-483E-8AE7-3992BEE1305F
P2860
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
The ALSFRS-R: a revised ALS fu ...... F ALS Study Group (Phase III).
@en
The ALSFRS-R: a revised ALS fu ...... function. BDNF ALS Study Group
@nl
type
label
The ALSFRS-R: a revised ALS fu ...... F ALS Study Group (Phase III).
@en
The ALSFRS-R: a revised ALS fu ...... function. BDNF ALS Study Group
@nl
prefLabel
The ALSFRS-R: a revised ALS fu ...... F ALS Study Group (Phase III).
@en
The ALSFRS-R: a revised ALS fu ...... function. BDNF ALS Study Group
@nl
P2093
P1476
The ALSFRS-R: a revised ALS fu ...... F ALS Study Group (Phase III).
@en
P2093
Cedarbaum JM
Nakanishi A
Stambler N
Thurmond B
P356
10.1016/S0022-510X(99)00210-5
P577
1999-10-01T00:00:00Z